SCIENCE 37

News

Science 37 related announcements, media, stories, and more.

SCIENCE 37

News

Science 37 related announcements, media, stories, and more.

Science 37 Completes Second FDA Inspection as Enrollment Leader in Phase 3 Asthma Trial

Science 37 Completes Second FDA Inspection as…

MORRISVILLE, NC — April 8, 2025 — Science 37, a leader in enhancing patient access…

/science-37-completes-second-fda-inspection-enrollment-leader-phase-3-asthma-trial

Science 37 Appoints Tyler Van Horn as CEO to Lead Next Era of Patient-Access Innovation

Science 37 Appoints Tyler Van Horn as CEO to Lead…

Seasoned Strategist and Former Chief Commercial Officer Poised to Accelerate Access…

/science-37-appoints-tyler-van-horn-ceo-lead-next-era-patient-access-innovation

Science 37 Nearly Doubles U.S. Enrollment for GSK Phase 3 Rare Disease Trial

Science 37 Nearly Doubles U.S. Enrollment for GSK…

MORRISVILLE, NC — November 21, 2024 — Science 37, a leader in enhancing patient…

https://www.science37.com/science-37-nearly-doubles-us-enrollment-gsk-phase-3-rare-disease-trial

Science 37 Earns Frost & Sullivan’s 2024 Global Company of the Year Award for Decentralized Clinical Trials

Science 37 Earns Frost & Sullivan’s 2024…

Top Honor Recognizes Science 37’s Visionary Innovation, Market-Leading Performance,…

/science-37-earns-frost-sullivans-2024-global-company-year-award-decentralized-clinical-trials

Science 37 Unveils New Corporate Headquarters in Research Triangle Park, NC

Science 37 Unveils New Corporate Headquarters in…

19,000-square-foot facility reflects the company’s recent growth and continued…

/science-37-unveils-new-corporate-headquarters-research-triangle-park-nc

Science 37 Enrolls 42% of Trial Cohort in 8 Weeks

Science 37 Enrolls 42% of Trial Cohort in 8 Weeks

Science 37 Supports Phase 3 Clinical Trial with Recruitment and Enrollment,…

/science-37-enrolls-42-trial-cohort-8-weeks

Science 37 Quickly Impacts Performance in Under-Enrolling Clinical Trials

Science 37 Quickly Impacts Performance in Under-…

Nearly 20 studies have successfully leveraged Science 37's medical and operational…

/science-37-quickly-impacts-performance-under-enrolling-clinical-trials

Science 37 Surpasses Enrollment Goals, Accelerates Phase 2 Rare Disease Clinical Trial

Science 37 Surpasses Enrollment Goals,…

Science 37 Enrolls 21% of Study Participants at 11x the Speed of Traditional…

/science-37-surpasses-enrollment-goals-accelerates-phase-2-rare-disease-clinical-trial

Science 37 Metasite™ Undergoes Successful FDA Inspection, Marking Major Milestone in Virtual Site Quality Assurance and Compliance

Science 37 Metasite™ Undergoes Successful FDA…

Science 37’s Virtual Site Model for Clinical Research Impresses in First-of-its-Kind…

/science-37-metasitetm-undergoes-successful-fda-inspection-marking-major-milestone-virtual-site

Science 37 Wins 2024 MedTech Breakthrough Award for “Clinical Efficiency Innovation”

Science 37 Wins 2024 MedTech Breakthrough Award…

Science 37’s Patient Recruitment Recognized in Prestigious International Annual…

/science-37-wins-2024-medtech-breakthrough-award-clinical-efficiency-innovation

Science 37 Delivers 22x Faster Enrollment than Traditional Methods in Phase 3 Asthma Clinical Trial

Science 37 Delivers 22x Faster Enrollment than…

Partnership with Leading Biotech Company Enrolls 28% of Study Participants with 22x…

/science-37-delivers-22x-faster-enrollment-traditional-methods-phase-3-asthma-clinical-trial

Science 37 Provides Fully-Consented Patients to Sites to Supplement Enrollment

Science 37 Provides Fully Consented Patients to…

New patent-protected, central recruitment offering leverages the Science 37 Metasite…

/science-37-provides-fully-consented-patients-sites-supplement-enrollment